Anti-inflammatory effects of GLP1-RA drugs - PubMed
4 hours ago
- #GLP-1 Receptor Agonists
- #Anti-inflammatory Effects
- #Cardiometabolic Disease
- GLP-1 receptor agonists (GLP-1RA) are used for type 2 diabetes and obesity, lowering glucose, reducing weight, and improving cardiovascular outcomes.
- Beyond metabolic benefits, GLP-1RA have direct anti-inflammatory effects across multiple organ systems, targeting diseases like diabetes, cardiovascular disease, neurodegenerative disorders, and inflammatory bowel disease.
- Evidence from preclinical models and clinical trials supports these anti-inflammatory effects, offering dual cardiometabolic and immunomodulatory protection.
- However, key questions remain on causality, molecular mechanisms, and effective translation of anti-inflammatory effects for non-metabolic inflammatory diseases.